BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2666426)

  • 1. Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal.
    Walker J; Chaussain JL; Bougnères PF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):253-8. PubMed ID: 2666426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of growth hormone treatment on insulin secretion and glucose metabolism in prepubertal boys with short stature.
    Aman J; Rosberg S; Albertsson-Wikland K
    Eur J Endocrinol; 1994 Sep; 131(3):246-50. PubMed ID: 7921208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity.
    de Zegher F; Ong K; van Helvoirt M; Mohn A; Woods K; Dunger D
    J Clin Endocrinol Metab; 2002 Jan; 87(1):148-51. PubMed ID: 11788639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism.
    Hannon TS; Danadian K; Suprasongsin C; Arslanian SA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3033-9. PubMed ID: 17519313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis.
    O'Neal DN; Kalfas A; Dunning PL; Christopher MJ; Sawyer SD; Ward GM; Alford FP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):975-83. PubMed ID: 7962308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients.
    Nørrelund H; Djurhuus C; Jørgensen JO; Nielsen S; Nair KS; Schmitz O; Christiansen JS; Møller N
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E737-43. PubMed ID: 12799313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic outcome of GH treatment in prepubertal short children with and without classical GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Nierop AF; Gustafsson J; Bosaeus I; Fors H; Hochberg Z; Dahlgren J
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):346-54. PubMed ID: 20455890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature.
    Heptulla RA; Boulware SD; Caprio S; Silver D; Sherwin RS; Tamborlane WV
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3234-8. PubMed ID: 9329345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
    Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G;
    J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid patterns in treated growth hormone deficient children vs. short stature controls.
    Foster C; Burton A; Scholl J; Scott ML; Gunter V; McCormick K
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):909-14. PubMed ID: 24859507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone action in puberty: effects by gender.
    Mauras N; Bishop K; Welch S
    Growth Horm IGF Res; 2007 Dec; 17(6):463-71. PubMed ID: 17566776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
    Marini JC; Bordenick S; Heavner G; Rose S; Hintz R; Rosenfeld R; Chrousos GP
    J Clin Endocrinol Metab; 1993 Jan; 76(1):251-6. PubMed ID: 8421094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone therapy on circadian osteocalcin rhythms in idiopathic short stature.
    Markowitz ME; DiMartino-Nardi J; Gasparini F; Fishman K; Rosen JF; Saenger P
    J Clin Endocrinol Metab; 1989 Aug; 69(2):420-5. PubMed ID: 2787800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.